Igor Oscorbin1,2, Andrey Kechin3,4, Uljana Boyarskikh3, Maxim Filipenko3,4. 1. Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia, 630090. osc.igor@gmail.com. 2. Novosibirsk State University, Novosibirsk, Russia, 630090. osc.igor@gmail.com. 3. Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia, 630090. 4. Novosibirsk State University, Novosibirsk, Russia, 630090.
Abstract
PURPOSE: Germinal and somatic rearrangements in BRCA1 gene play a significant role in carcinogenesis of breast and ovarian cancer. The present study is dedicated to the development of multiplex droplet digital PCR (ddPCR) assay for detecting large deletions and duplications in the BRCA1 gene. METHODS: In-house tetraplex ddPCR assay for BRCA1 gene analysis was used for testing of DNA samples with BRCA1 status. RESULTS: DNA specimens were purified from 24 individuals. The presence of BRCA1 rearrangements in samples was confirmed by a commercial MLPA-based kit. An amplitude-based multiplex ddPCR assay was developed: 8 multiplexes, each containing primers and probes to amplify 3 BRCA1 exons and 1 reference gene (ALB or RPP30). A novel assay demonstrated 100% concordance with the commercial MLPA-based kit, identifying 9 specimens with different deletions in BRCA1, 1 with duplication, and 14 with the wild-type BRCA1. CONCLUSIONS: We have designed a simple, precise, and cost-effective assay for BRCA1 rearrangement testing, based on ddPCR. The developed assay is the first multiplex ddPCR-based test that provides results in accordance with MLPA and can be used for routine clinical screening.
PURPOSE: Germinal and somatic rearrangements in BRCA1 gene play a significant role in carcinogenesis of breast and ovarian cancer. The present study is dedicated to the development of multiplex droplet digital PCR (ddPCR) assay for detecting large deletions and duplications in the BRCA1 gene. METHODS: In-house tetraplex ddPCR assay for BRCA1 gene analysis was used for testing of DNA samples with BRCA1 status. RESULTS: DNA specimens were purified from 24 individuals. The presence of BRCA1 rearrangements in samples was confirmed by a commercial MLPA-based kit. An amplitude-based multiplex ddPCR assay was developed: 8 multiplexes, each containing primers and probes to amplify 3 BRCA1 exons and 1 reference gene (ALB or RPP30). A novel assay demonstrated 100% concordance with the commercial MLPA-based kit, identifying 9 specimens with different deletions in BRCA1, 1 with duplication, and 14 with the wild-type BRCA1. CONCLUSIONS: We have designed a simple, precise, and cost-effective assay for BRCA1 rearrangement testing, based on ddPCR. The developed assay is the first multiplex ddPCR-based test that provides results in accordance with MLPA and can be used for routine clinical screening.
Entities:
Keywords:
BRCA1; CNV; Digital PCR; Gene rearrangements; Multiplex amplification
Authors: Soo-Ryum Yang; Yosr Bouhlal; Francisco M De La Vega; Morgan Ballard; Calvin J Kuo; Anna Vilborg; Greg Jensen; Kimberly Allison Journal: Mod Pathol Date: 2020-03-11 Impact factor: 7.842
Authors: Erin C Boone; Wendy Y Wang; Roger Gaedigk; Mariana Cherner; Anick Bérard; J Steven Leeder; Neil A Miller; Andrea Gaedigk Journal: Front Pharmacol Date: 2020-05-08 Impact factor: 5.810
Authors: Igor P Oscorbin; Maria A Smertina; Ksenia A Pronyaeva; Mikhail E Voskoboev; Ulyana A Boyarskikh; Andrey A Kechin; Irina A Demidova; Maxim L Filipenko Journal: Cancers (Basel) Date: 2022-03-11 Impact factor: 6.639